BioWorld Appointments and advancements for January 6, 2025
January 6, 2025

See today’s BioWorld

New hires and promotions in the biopharma industry, including: Amylyx, Beigene, Blossomhill, Halia, Iambic, Perspective, Portage, Septerna, Unity.

Amylyx Pharmaceuticals Inc., of Cambridge, Mass., named Dan Monahan chief commercial officer.

Beigene Ltd., of Basel, Switzerland, appointed Giancarlo Benelli senior vice president and head of Europe.

Blossomhill Therapeutics Inc., of San Diego, named Geoff Oxnard chief medical officer and executive vice president and Ashley Preston senior vice president and head of regulatory affairs and quality assurance.

Halia Therapeutics Inc., of Lehi, Utah, added Gary Sabin to its board and promoted Margit Janat-Amsbury to chief scientific officer. The company also appointed Tracey Clayton vice president of program management and clinical operations and Stephen Anthony senior vice president of clinical development.

Iambic Therapeutics Inc., of San Diego, named Michael Secora chief corporate development officer and chief financial officer.

Perspective Therapeutics Inc., of Seattle, appointed Juan Graham chief financial officer.

Portage Biotech Inc., of Westport, Conn., announced the appointment of Peter Molloy as CEO of its re-launched, wholly-owned subsidiary Cyncado Therapeutics Inc.

Septerna Inc., of South San Francisco, named Gil Labrucherie chief financial officer.

Unity Biotechnology Inc., of South San Francisco, appointed Federico Grossi chief medical officer.